Roche’s Avastin helps colorectal cancer patients

	Tweet

Patients with advanced colorectal cancer who received Roche’s Avastin live longer when they also receive the drug as part of their second round of treatment, the Swiss drugmaker said on Thursday, citing a late-stage study.

Patients with metastatic colorectal cancer first treated with Avastin and standard chemotherapy before being given Avastin with a different chemotherapy after their disease had progressed lived significantly longer than those given only chemotherapy in the second-line setting, Roche said.

The news is likely to boost sentiment around the drug, which recently suffered a major setback when U.S. authorities decided to revoke their backing of its use in breast cancer.

Roche will submit the results of the ML 18147 study at an upcoming medical meeting.

In Europe, Avastin is currently approved in colorectal, lung, renal, breast cancer and it has just won approval in ovarian cancer.

###

(Reuters)

RELATED STORIES:
A less painful colonoscopy   Drinking Red Wine Cuts Risk of Colorectal Cancer   Vitamin D levels tied to colon cancer risk   Pain pills may cut risk of bowel cancer: study   Coffee and sodas not tied to colon cancer   Colorectal Cancer Awareness Month Resources from the AGA   Hormone Therapy Offers Potential Protective Effect Against Colon Cancer In Older Women   Regular Screenings and Healthy Living Reduce Colon Cancer Risk   Smoking can double risk of colorectal polyps   Colon Cancer Linked to Lineage   Preventing bowel cancer in high risk families   Protein found in heart may be target for colon cancer therapies   Use of Low-Dose Aspirin Associated with Improved Performance of Test for Detecting Colorectal Cancer   Study confirms red meat link with bowel cancer   Colorectal cancer survival advantage in MUTYH-associated polyposis   Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival   Study Finds Evidence of Gender-Related Differences In Development of Colon Cancer   Fecal immunochemical testing best and most cost-effective method for screening for colorectal cancer   Obesity Increases the Risk for Colorectal Cancer and Polyps   Metabolic syndrome ups colorectal cancer risk   Researchers Find Four Biomarkers Important in Colerectal Cancer Treatment Prognosis   Racial gap in colon cancer diagnosis, treatment

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]